Early-stage and small to midsize private and public companies in the life sciences sector began 2020 on a high note. Funding, particularly in the biotechnology sector, was pouring into the industry. Even several months into...more
12/7/2020
/ Biotechnology ,
C-Suite Executives ,
Clinical Trials ,
Coronavirus/COVID-19 ,
Funding ,
Investment Funds ,
Life Sciences ,
Midsize Businesses ,
Pharmaceutical Industry ,
Small Business ,
Startups